What should you know about non seminoma?

Non-seminoma differs from seminoma because it can include embryonal carcinoma, yolk sac tumour, choriocarcinoma or teratoma components. A tumour can contain more than one component. Doctors use the pathology report, tumour markers such as AFP and hCG, imaging and examination to understand the diagnosis.

These tumours often begin in a testicle, although germ-cell tumours can occur elsewhere. The location, marker pattern and whether disease has spread affect the treatment plan. A marker result is interpreted with scans and tissue findings, not on its own.

Ask for a clear explanation of the pathology, marker results and scan findings. Treatment may involve removal of the affected tumour, followed by chemotherapy when the team considers it appropriate. Specialists should discuss fertility before treatment, because surgery or chemotherapy can affect reproductive function.

Keep appointments for marker checks and imaging, and report new pain, swelling or breathing symptoms. If you are offered a treatment plan, ask how each step fits the diagnosis, what side effects to expect, and how response will be monitored.

Seek urgent care for sudden severe testicular pain, rapidly increasing swelling, difficulty breathing, chest pain, fainting or severe vomiting. Contact the oncology team promptly for fever during chemotherapy, new neurological symptoms or pain that is worsening rather than settling.

Which non-seminoma components are present? What do my AFP and hCG results mean with the scans? Is surgery recommended first, and what would it involve? Will chemotherapy be needed? Should I arrange sperm preservation before treatment? How will follow-up check for response or recurrence?